ResApp Expands Research Collaboration With Mass General for Diagnostic App

ResApp Nabs $12.5M For Smartphone App That Instantly Diagnose Respiratory Diseases

ResApp, a Australian-based digital health startup that has developed a smartphone app that can diagnose respiratory diseases based on the sound signatures of the coughs has entered into a two-year expanded research collaboration with Massachusetts General Hospital (MGH). As part of the research collaboration, ResApp and MGH will perform additional analysis of the SMARTCOUGH-C study data, use the SMARTCOUGH-C dataset to investigate the state of respiratory disease clinical practice today and
Read More

Thought you might find this interesting










Submit

Propeller Health Lands FDA 510(k) Clearance to Market Sensor for the Ellipta Inhaler

Propeller Health Lands FDA 510(k) Clearance to Market Digital Sensor for the Ellipta Inhaler

Propeller Health, a Madison, Wisconsin-based provider of digital solutions for respiratory medicine has received FDA 510(k) clearance to market its digital sensor for use with GSK’s Ellipta® patented, dry powder inhaler. The custom sensor designed exclusively for the Ellipta inhaler was cleared as part of a R&D collaboration between Propeller and GSK announced in late 2015.For the R&D collaboration, the Propeller sensor automatically collected and recorded data on the Ellipta inhaler's
Read More

Thought you might find this interesting










Submit

Propeller Health Lands $21.5M to Modernize Respiratory Disease Management

Propeller Health

Propeller Health, a digital solution for respiratory medicine has raised $21.5 million in Series C funding from 3M Ventures, S.R. One, Limited, Hikma Ventures and existing investors Safeguard Scientifics and Social Capital. The round also includes participation from existing investors Safeguard Scientifics and Social Capital. The company plans to utilize the funding to expand Propeller’s FDA-cleared digitally-guided therapy platform. Despite an abundance of effective medications, the burden of
Read More

Thought you might find this interesting










Submit

Propeller Health, Aptar Partner To Develop Connected Metered Dose Inhaler

Propeller Health

Digital health company Propeller Health is teaming up with Aptar Pharma (Aptar) to develop  the world's first integrated connected metered dose inhaler (cMDI), with an integrated sensor and a novel electronic dose counter. The device is currently available for licensing and is expected to enter clinical studies later this year. Connected Metered Dose Inhaler Development Details Pressurized MDIs are the most common type of inhaler device on the market today, with over 600 million units
Read More

Thought you might find this interesting










Submit